These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22723997)

  • 1. Genotype-specific differences between mouse CNS stem cell lines expressing frontotemporal dementia mutant or wild type human tau.
    Orr ME; Pitstick R; Canine B; Ashe KH; Carlson GA
    PLoS One; 2012; 7(6):e39328. PubMed ID: 22723997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy.
    Koller EJ; Gonzalez De La Cruz E; Machula T; Ibanez KR; Lin WL; Williams T; Riffe CJ; Ryu D; Strang KH; Liu X; Janus C; Golde TE; Dickson D; Giasson BI; Chakrabarty P
    Hum Mol Genet; 2019 Oct; 28(19):3255-3269. PubMed ID: 31261380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking Site-Specific Cleavage of Human Tau Delays Progression of Disease-Related Phenotypes in Genetically Matched Tau-Transgenic Mice Modeling Frontotemporal Dementia.
    Steuer EL; Kemper LJ; Hlynialuk CJW; Leinonen-Wright K; Montonye ML; Lapcinski IP; Forster CL; Ashe KH; Liu P
    J Neurosci; 2022 Jun; 42(23):4737-4754. PubMed ID: 35508385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G272V and P301L Mutations Induce Isoform Specific Tau Mislocalization to Dendritic Spines and Synaptic Dysfunctions in Cellular Models of 3R and 4R Tau Frontotemporal Dementia.
    Yu K; Yao KR; Aguinaga MA; Choquette JM; Liu C; Wang Y; Liao D
    J Neurosci; 2024 Jul; 44(28):. PubMed ID: 38858079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial Note: Genotype-Specific Differences between Mouse CNS Stem Cell Lines Expressing Frontotemporal Dementia Mutant or Wild Type Human Tau.
    PLOS ONE Editors
    PLoS One; 2024; 19(6):e0305843. PubMed ID: 38935762
    [No Abstract]   [Full Text] [Related]  

  • 6. Frontotemporal Dementia P301L Mutation Potentiates but Is Not Sufficient to Cause the Formation of Cytotoxic Fibrils of Tau.
    Wang KW; Zhang G; Kuo MH
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optic nerve thinning and neurosensory retinal degeneration in the rTg4510 mouse model of frontotemporal dementia.
    Harrison IF; Whitaker R; Bertelli PM; O'Callaghan JM; Csincsik L; Bocchetta M; Ma D; Fisher A; Ahmed Z; Murray TK; O'Neill MJ; Rohrer JD; Lythgoe MF; Lengyel I
    Acta Neuropathol Commun; 2019 Jan; 7(1):4. PubMed ID: 30616676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced number of axonal mitochondria and tau hypophosphorylation in mouse P301L tau knockin neurons.
    Rodríguez-Martín T; Pooler AM; Lau DHW; Mórotz GM; De Vos KJ; Gilley J; Coleman MP; Hanger DP
    Neurobiol Dis; 2016 Jan; 85():1-10. PubMed ID: 26459111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated neurodegeneration and neuroinflammation in transgenic mice expressing P301L tau mutant and tau-tubulin kinase 1.
    Asai H; Ikezu S; Woodbury ME; Yonemoto GM; Cui L; Ikezu T
    Am J Pathol; 2014 Mar; 184(3):808-18. PubMed ID: 24418258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia.
    Seo J; Kritskiy O; Watson LA; Barker SJ; Dey D; Raja WK; Lin YT; Ko T; Cho S; Penney J; Silva MC; Sheridan SD; Lucente D; Gusella JF; Dickerson BC; Haggarty SJ; Tsai LH
    J Neurosci; 2017 Oct; 37(41):9917-9924. PubMed ID: 28912154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased synthesis of ribosomal proteins in tauopathy revealed by non-canonical amino acid labelling.
    Evans HT; Benetatos J; van Roijen M; Bodea LG; Götz J
    EMBO J; 2019 Jul; 38(13):e101174. PubMed ID: 31268600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human iPSC-Derived Neuronal Model of Tau-A152T Frontotemporal Dementia Reveals Tau-Mediated Mechanisms of Neuronal Vulnerability.
    Silva MC; Cheng C; Mair W; Almeida S; Fong H; Biswas MHU; Zhang Z; Huang Y; Temple S; Coppola G; Geschwind DH; Karydas A; Miller BL; Kosik KS; Gao FB; Steen JA; Haggarty SJ
    Stem Cell Reports; 2016 Sep; 7(3):325-340. PubMed ID: 27594585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between a MAPT variant causing frontotemporal dementia and mutant APP affects axonal transport.
    Adalbert R; Milde S; Durrant C; Ando K; Stygelbout V; Yilmaz Z; Gould S; Brion JP; Coleman MP
    Neurobiol Aging; 2018 Aug; 68():68-75. PubMed ID: 29729423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau-mediated nuclear depletion and cytoplasmic accumulation of SFPQ in Alzheimer's and Pick's disease.
    Ke YD; Dramiga J; Schütz U; Kril JJ; Ittner LM; Schröder H; Götz J
    PLoS One; 2012; 7(4):e35678. PubMed ID: 22558197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L).
    Ramsden M; Kotilinek L; Forster C; Paulson J; McGowan E; SantaCruz K; Guimaraes A; Yue M; Lewis J; Carlson G; Hutton M; Ashe KH
    J Neurosci; 2005 Nov; 25(46):10637-47. PubMed ID: 16291936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPT.
    Sposito T; Preza E; Mahoney CJ; Setó-Salvia N; Ryan NS; Morris HR; Arber C; Devine MJ; Houlden H; Warner TT; Bushell TJ; Zagnoni M; Kunath T; Livesey FJ; Fox NC; Rossor MN; Hardy J; Wray S
    Hum Mol Genet; 2015 Sep; 24(18):5260-9. PubMed ID: 26136155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau filament formation in transgenic mice expressing P301L tau.
    Götz J; Chen F; Barmettler R; Nitsch RM
    J Biol Chem; 2001 Jan; 276(1):529-34. PubMed ID: 11013246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disinhibition-like behavior in a P301S mutant tau transgenic mouse model of frontotemporal dementia.
    Przybyla M; Stevens CH; van der Hoven J; Harasta A; Bi M; Ittner A; van Hummel A; Hodges JR; Piguet O; Karl T; Kassiou M; Housley GD; Ke YD; Ittner LM; van Eersel J
    Neurosci Lett; 2016 Sep; 631():24-29. PubMed ID: 27521751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontotemporal dementia with Parkinsonism linked to chromosome-17 mutations enhance tau oligomer formation.
    Maeda S; Sato Y; Takashima A
    Neurobiol Aging; 2018 Sep; 69():26-32. PubMed ID: 29852407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.
    Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW
    Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.